explore -WSS

explore

author：entertainment 2025-09-06 02:04:51 - browse：38736

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Health AI adoption puts security, privacy startups on investors' radar

entertainment

WSS

STAT's guide to the next generation of CAR

Future doctors should be trained to promote social change

Leading voice in opioid treatment defends methadone clinic system

Donald Trump's relentless attacks on special counsel Jack Smith

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

UnitedHealth increases loan offers after Change Healthcare outage

hotspot

explore

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

UnitedHealth increases loan offers after Change Healthcare outage

Continuity nursing helped my family in our darkest PICU moments

Baby aspirin cuts fat buildup in liver disease patients, in small study

23andMe had bad news about my health. I wish a person had delivered it

Intermittent fasting comes with a heart risk? Not so fast

The cancer drug shortage isn’t new — and neither are the solutions

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

As demand for Covid shots wanes, Moderna seeks its next success

Asbestos, a deadly carcinogen, banned by EPA

leisure time

The story of mRNA: From a loose idea to a tool that may help curb Covid

#NeedHerScience: shining a light on gender disparities in medicine

Physicians and social media: If you see something, say something?

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Physicians and social media: If you see something, say something?

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

hotspot

entertainment

focus

focus